Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022:1400:53-63.
doi: 10.1007/978-3-030-97182-3_4.

Schizophrenia Outside the Brain

Aline Gazzola Fragnani Valença  1 , Bradley Joseph Smith  2
Affiliations

Schizophrenia Outside the Brain

Aline Gazzola Fragnani Valença et al. Adv Exp Med Biol. 2022.

Abstract

Schizophrenia is a multifactorial mental disorder, characterized by positive symptoms (delusions, hallucinations), negative symptoms (anhedonia, social withdraw), and cognitive symptoms (impairment of memory, learning, and executive functions). Despite the classic symptoms being related to the central nervous system, schizophrenia has been described by recent studies as a systemic disease, affecting other organs, tissues, and systems out of the brain. In this chapter, we summarize the main tissues and systems found affected in schizophrenic patients, both before and after antipsychotic administration. We offer an overview of the recent findings in the field about musculoskeletal system, metabolism, and immune system dysfunctions found in patients as well in models in vitro. We also discuss some of the side effects of certain antipsychotics often related to increased risk of comorbidities in patients with schizophrenia during the treatment.

Keywords: Adipose tissue; Immune system; Metabolic syndrome; Schizophrenia; and Psychiatry.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Ali, T., Sisay, M., Tariku, M., Mekuria, A. N., & Desalew, A. (2021). Antipsychotic-induced extrapyramidal side effects: A systematic review and meta-analysis of observational studies. PLoS One, 16(9), e0257129. - PubMed - PMC - DOI
    1. Andreasen, N. C., Arndt, S., Alliger, R., Miller, D., & Flaum, M. (1995). Symptoms of schizophrenia. Methods, meanings, and mechanisms. Archives of General Psychiatry, 52(5), 341–351. - PubMed - DOI
    1. Arias, I., Sorlozano, A., Villegas, E., de Dios Luna, J., McKenney, K., Cervilla, J., Gutierrez, B., & Gutierrez, J. (2012). Infectious agents associated with schizophrenia: A meta-analysis. Schizophrenia Research, 136(1-3), 128–136. - PubMed - DOI
    1. Ascher-Svanum, H., Nyhuis, A. W., Stauffer, V., Kinon, B. J., Faries, D. E., Phillips, G. A., Kory, S., George Awad, A., Keefe, R., & Naber, D. (2010). Reasons for discontinuation and continuation of antipsychotics in the treatment of schizophrenia from patient and clinician perspectives. Current Medical Research and Opinion, 26(10), 2403–2410. - PubMed - DOI
    1. Bahorik, A. L., Satre, D. D., Kline-Simon, A. H., Weisner, C. M., & Campbell, C. I. (2017). Serious mental illness and medical comorbidities: Findings from an integrated health care system. Journal of Psychosomatic Research, 100(September), 35–45. - PubMed - PMC - DOI

Substances

LinkOut - more resources